Wheeler DC, Stefansson BV, Batiushin M, Bilchenko O, et al. The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics. Nephrol Dial Transplant 2020 Aug 30. pii: 5899227. doi: 10.1093.
PMID: 32862232